v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2024
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:                
Net loss   $ (1,268,142) $ (3,222,892) $ (1,981,293) $ (15,941,328) $ (4,491,034) $ (17,922,621)  
Adjustments to reconcile net loss to net cash flows used in operating activities:                
Amortization of debt discount           1,583,890  
Interest expense           817,824  
(Gain) loss on extinguishment of debt   (1,353,679)   364,109   (1,115,455) 364,109  
Change in fair value of derivative liabilities and convertible notes   275   289,401   (251,532) 384,318  
Interest capitalized           9,008  
Inventory write-off   42,372       42,372  
Stock-based compensation expense           157,500 14,131,250  
Changes in operating assets and liabilities:                
Prepaid expenses and other current assets           (954,856) (553,833)  
Inventories           (77,662)  
Accounts payable           (11,946) 1,041,420  
Accrued expenses           (44,481) (15,359)  
Due from related party           (1,027,920)  
Other current liabilities           (111,026)  
Net cash flows used in operating activities           (5,154,196) (2,891,838)  
Cash flows from financing activities:                
Issuance of Series A convertible preferred stock $ 2,500,000         17,951,119  
Proceeds from Reverse Recapitalization           265,828  
Proceeds from issuance of convertible notes           3,000,000  
Deferred financing costs           (75,000)  
Proceeds from debenture           2,000,000  
Repayment of debenture           (2,173,913)  
Proceeds from notes payable - related party           50,000  
Repayment of notes payable – related party           (1,384,778) (221,390)  
Net cash flows provided by financing activities           16,317,428 3,094,438  
Net increase in cash and cash equivalents           11,163,232 202,600  
Cash and cash equivalents, beginning of the period     $ 1,003,904   $ 3,633 1,003,904 3,633 $ 3,633
Cash and cash equivalents, end of the period $ 3,633 12,167,136   $ 206,233   12,167,136 206,233 1,003,904
Supplemental cash flow information:                
Cash paid for interest            
Supplemental disclosure of non-cash investing and financing activities:                
Conversion of convertible notes to common stock           163,817  
Issuance of incentive shares pursuant to the January 2026 Share Purchase Agreement           1,390,400  
Issuance of shares pursuant to debt exchange agreements           2,005,141  
Conversion of convertible notes to Series A convertible preferred stock           943,801  
Conversion of Series A convertible preferred stock to common stock         112  
Issuance of commitment fee shares under ELOC agreement           13,406  
Due to affiliate write-off           353,679  
Accounts payable and other liabilities combined, net           1,577,057  
Promissory note fee - related party, write-off           1,000,000  
Promissory note fee - related party, combined           1,000,000 1,000,000
Subscription agreement loans combined           1,828,098 1,828,098
Loan and transfer notes payable combined           499,214  
Forward purchase agreement liability combined           49,034 $ 49,034
Issuance of common stock for services           $ 157,500 $ 14,448,500